All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Mounjaro and Fertility

Mounjaro should be discontinued at least one month before trying to conceive. Learn about its fertility effects, weight loss benefits for reproduction,...

By Dr. James Walker, MD, MPH|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. James Walker, MD, MPH · Reviewed by Dr. David Kim, MD, FACE

Mounjaro and Fertility custom 2026 header image for GLP-1 Weight Loss
Custom header image for Mounjaro and Fertility, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Mounjaro and Fertility

Mounjaro should be discontinued at least one month before trying to conceive. Learn about its fertility effects, weight loss benefits for reproduction,...

Short answer

Mounjaro should be discontinued at least one month before trying to conceive. Learn about its fertility effects, weight loss benefits for reproduction,...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Mounjaro should be discontinued at least one month before trying to conceive. Learn about its fertility effects, weight loss benefits for reproduction, contraception guidance, and PCOS impact.

Mounjaro (tirzepatide) should be discontinued at least one month before you try to become pregnant. It isn't approved for use during pregnancy. But the dramatic weight loss many patients experience on Mounjaro can positively impact fertility by restoring hormonal balance and ovulatory function in those affected by obesity. Working with your provider on timing is critical.

Mounjaro was originally approved for type 2 diabetes, but its weight loss effects have made it one of the most talked-about medications in reproductive health circles. Many patients prescribed Mounjaro are women in their 20s, 30s, and 40s who are actively thinking about family planning.

When to Stop Mounjaro Before Conception

Tirzepatide, the active ingredient in Mounjaro, has a half-life of about five days. After your final injection, it takes roughly four to five weeks for the drug to be effectively eliminated. The prescribing information recommends stopping at least one month before planned pregnancy.

This recommendation is based on animal studies where high doses of tirzepatide caused adverse developmental effects in offspring. Human pregnancy data isn't available in sufficient quantity to override this precaution. Planning your washout period in advance with your fertility team ensures a smooth transition from treatment to conception.

How Mounjaro Weight Loss Supports Fertility

Obesity impairs fertility through multiple pathways: excess estrogen from fat tissue, insulin resistance disrupting ovulation, chronic inflammation affecting egg and sperm quality, and higher rates of pregnancy complications. Mounjaro addresses several of these through substantial weight reduction and metabolic improvement. For a complete cost breakdown, see our compare tirzepatide pharmacies.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Mounjaro and Fertility

Patients on Mounjaro in clinical trials lost an average of 15% to 22.5% of their body weight at the highest doses. For someone weighing 250 pounds, that translates to losing 37 to 56 pounds. This magnitude of change can shift a patient from anovulatory to regularly ovulating, from failed IVF cycles to successful ones, and from high-risk pregnancy territory to much safer ground.

Mounjaro and PCOS

Polycystic ovary syndrome is closely linked to insulin resistance and weight. Mounjaro's dual GIP/GLP-1 mechanism addresses both of these factors directly. By improving insulin sensitivity and reducing body weight, Mounjaro may help PCOS patients resume regular ovulatory cycles.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

This is a double-edged sword for patients not trying to conceive. If you have PCOS and start ovulating again while on Mounjaro, your risk of unplanned pregnancy increases. Use consistent contraception if pregnancy isn't desired. tirzepatide and PCOS

Contraception on Mounjaro

Mounjaro's prescribing information warns that delayed gastric emptying may reduce the effectiveness of oral hormonal contraceptives. The recommendation is to use an additional non-oral backup method for four weeks after starting Mounjaro and for four weeks after each dose increase. IUDs, contraceptive implants, patches, and injectable contraceptives aren't affected by gastric motility changes.

Frequently Asked Questions

How long before conception should I stop Mounjaro?

Stop Mounjaro at least one month before trying to conceive. Given tirzepatide's five-day half-life, the drug should be substantially cleared from your body within that timeframe. Your provider may recommend a slightly longer window depending on your circumstances.

Can Mounjaro cause permanent infertility?

There's no evidence that Mounjaro causes permanent infertility in humans. The precautionary recommendation to stop before pregnancy is based on animal study findings at doses exceeding human therapeutic levels. For many patients, Mounjaro's weight loss benefits may actually enhance fertility.

What should I do if I get pregnant while on Mounjaro?

Discontinue Mounjaro immediately and contact your healthcare provider. The effects of early-pregnancy exposure to tirzepatide in humans aren't well studied. Your provider will arrange appropriate monitoring and guide next steps.

Does Mounjaro affect oral birth control?

Mounjaro may reduce oral contraceptive absorption because it delays gastric emptying. The prescribing label recommends a backup non-oral contraceptive method for four weeks after starting Mounjaro and after each dose increase. Non-oral options like IUDs and implants remain fully effective. GLP-1 drug interactions

Potentially, yes. Weight loss and improved insulin sensitivity from Mounjaro may restore ovulation in women with PCOS. Some reproductive specialists use a weight loss phase with Mounjaro before fertility treatment, followed by a proper washout period before conception attempts. Mounjaro for weight loss

This content is for informational purposes only and doesn't constitute medical advice. Always consult a qualified healthcare provider regarding fertility and medication decisions.

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
Mounjaro evidence source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Mounjaro and Fertility, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialTirzepatide evidence2022

Tirzepatide Once Weekly for the Treatment of Obesity

Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.

PubMed

Randomized trialTirzepatide evidence2024

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction

Used for continuation, stopping, and maintenance questions after initial weight loss.

PubMed

Randomized trialTirzepatide evidence2025

Tirzepatide for Obesity Treatment and Diabetes Prevention

Supports newer discussion of obesity treatment and diabetes-prevention outcomes.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewPCOS and GLP-1 evidence2019

GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis

Used for PCOS pages comparing metabolic and weight-management approaches.

PubMed

Systematic reviewPCOS and GLP-1 evidence2024

The efficacy and safety of GLP-1 agonists in PCOS women living with obesity

Supports PCOS, obesity, and hormonal-regulation context.

PubMed

Systematic reviewPCOS and GLP-1 evidence2026

GLP-1 receptor agonist treatment in women with polycystic ovary syndrome

Current review source for pages discussing GLP-1 treatment in PCOS.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Mounjaro and Fertility research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Mounjaro should be discontinued at least one month before trying to conceive. Learn about its fertility effects, weight loss benefits for reproduction, contraception guidance, and PCOS impact. "Mounjaro and Fertility" is meant to make a complicated topic easier to discuss, not to flatten it into a one-size answer. FormBlends frames it around patient education and clinical context, with extra attention to tirzepatide. Because this article has 5 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. If the next step affects treatment or sourcing, use the article to prepare questions for a licensed clinician.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Mounjaro and Fertility

Mounjaro and Fertility now carries extra 2026 context around semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, mounjaro, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation.

Instead of adding filler, this page keeps the named treatment terms, practical verification points, and next-step questions close to mounjaro and fertility.

Readers should use the section to check current eligibility, pharmacy or provider policies, and safety questions with a licensed professional before acting.

Mounjaro and Fertility custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Mounjaro and Fertility, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Mounjaro and Fertility, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. James Walker, MD, MPH

Internal Medicine. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.